SCHEMBL8062325

SCHEMBL8062325

CC(=O)NC1C(O[C@@H]2OC(C(=O)O)[C@@H](O)C(O)C2O)[C@H](O)C(CO)O[C@H]1O

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.59
▸ LGALS3 P17931 5/20 0.49
▸ LGALS8 O00214 1/20 0.49
▸ LGALS4 P56470 1/20 0.49
▸ BDNF P23560 3/20 0.45
▸ PTN P21246 2/20 0.45
▸ MDK P21741 2/20 0.45
▸ CD69 Q07108 1/20 0.44
▸ NOD2 Q9HC29 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ CHIA Q9BZP6 1/20 0.40
▸ LGALS1 P09382 1/20 0.39
▸ LGALS7; LGALS7B P47929 1/20 0.39
▸ FGF1 P05230 1/20 0.39
▸ FGF2 P09038 1/20 0.39
▸ VEGFA P15692 1/20 0.39
▸ HPSE Q9Y251 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19864355 1.00 MAPK1 (0.59) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL29533003 1.00 MAPK1 (0.59) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL12878533 1.00 MAPK1 (0.59) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL30055691 1.00 MAPK1 (0.59) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL29472159 1.00 MAPK1 (0.59) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL24484198 0.94 MDK (0.53) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL6748051 0.94 MDK (0.53) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL22071113 0.94 MDK (0.53) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL20516492 0.94 MDK (0.53) MAPK1LGALS3LGALS8LGALS4BDNF
SCHEMBL31067693 0.94 MDK (0.53) MAPK1LGALS3LGALS8LGALS4BDNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009039195-A1 RESVERATROL-CONTAINING COMPOSITIONS FOR MODULATING GENE PRODUCT CONCENTRATION OR ACTIVITY RESVERATROL PARTNERS, LLC (US) 2009-03-26 — — WO disclosed
Send feedback